Literature DB >> 10501492

Endothelial cell infection in vivo by equine infectious anaemia virus.

J Lindsay Oaks1, Catherine Ulibarri1, Timothy B Crawford1.   

Abstract

Equine infectious anaemia virus (EIAV) infection of horses is characterized clinically by recurrent episodes of fever, thrombocytopenia and anaemia. In vivo, the only site of virus replication that has been previously demonstrated for EIAV is the tissue macrophage. In this study, in situ hybridization for EIAV was combined with immunohistochemistry for cell-type-specific markers to identify infected endothelial cells. EIAV-infected endothelial cells and macrophages were detected in horses infected with either virulent wild-type or with weakly virulent tissue culture-adapted strains of EIAV. The role of endothelial cell infection in the pathogenesis of EIAV remains undefined, but could contribute to the development of thrombocytopenia. However, endothelial cell infection does not appear to be a determinant of virulence for EIAV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501492     DOI: 10.1099/0022-1317-80-9-2393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.

Authors:  Darrilyn G Fraser; Robert H Mealey; Travis C McGuire
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

2.  Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Authors:  C Leroux; J K Craigo; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Characterization of equine E-selectin.

Authors:  J F Hedges; C D Demaula; B D Moore; B E McLaughlin; S I Simon; N J MacLachlan
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

4.  Ensuring Viral Safety of Equine Immunoglobulins during Production.

Authors:  V V Mashin; A N Sergeev; N N Martynova; M D Oganov; A A Sergeev; V V Kataeva; N V Zagidullin
Journal:  Pharm Chem J       Date:  2022-05-07       Impact factor: 1.063

5.  An equine infectious anemia virus variant superinfects cells through novel receptor interactions.

Authors:  Melinda A Brindley; Baoshan Zhang; Ronald C Montelaro; Wendy Maury
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.

Authors:  Cheng Du; Jian Ma; Qiang Liu; Yun-Fei Li; Xi-Jun He; Yue-Zhi Lin; Xue-Feng Wang; Qing-Wen Meng; Xiaojun Wang; Jian-Hua Zhou
Journal:  Retrovirology       Date:  2015-04-28       Impact factor: 4.602

7.  Interstitial lung disease associated with Equine Infectious Anemia Virus infection in horses.

Authors:  Pompei Bolfa; Marie Nolf; Jean-Luc Cadoré; Cornel Catoi; Fabienne Archer; Christine Dolmazon; Jean-François Mornex; Caroline Leroux
Journal:  Vet Res       Date:  2013-12-01       Impact factor: 3.683

8.  Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response.

Authors:  Qiang Liu; Jian Ma; Xue-Feng Wang; Fei Xiao; Li-Jia Li; Jiao-Er Zhang; Yue-Zhi Lin; Cheng Du; Xi-Jun He; Xiaojun Wang; Jian-Hua Zhou
Journal:  Vet Immunol Immunopathol       Date:  2016-01-23       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.